Clinical Trial

Biomarkers of Immune-Related Toxicity

Name: Biomarkers of Immune-Related Toxicity — clinical trial record (NCT03409016)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

This is a single-center, correlative pilot study evaluating potential biomarkers predictive of immune-related adverse events associated with immune checkpoint inhibitor therapy.

Protocol Amendment History 1 change

minor Completion pushed: 2026-05-28 -> 2026-10-17 2026-08-06

Trial Details

NCT Number	NCT03409016
Lead Sponsor	University of Colorado, Denver Collaborators: Cancer League of Colorado
Conditions	Cancer, Metastatic Cancer
Enrollment	69 participants
Start Date	2018-04-18
Primary Completion	2025-05-28 (estimated)
Study Completion	2026-10-17 (estimated)
Updated on ClinicalTrials.gov	2026-08-05